Press Release – New York, NY – May 21, 2026 – Sichenzia Ross Ference Carmel LLP announced that it represented D. Boral Capital as the exclusive placement agent for the recently priced $2 million registered direct offering of Jupiter Neurosciences, Inc. (Nasdaq: JUNS), a clinical-stage biopharmaceutical company focused on central nervous system disorders and neuroinflammation.
The D. Boral Capital team was led by David Boral, Philip Wiederlight, Mark Iorio, David Sans, Zach Perotto and Michael Fellman.
The SRFC team was led by partner Ross Carmel, with associates Jesse Blue, Benjamin Sklar and Brady Berman.